Price Alert

AdaptHealth Corp. (AHCO)

NASDAQ: AHCO · Real-Time Price · USD

9.48

-0.01 (-0.11%)

At close: Aug 15, 2025, 3:59 PM

9.45

-0.32%

After-hours: Aug 15, 2025, 07:42 PM EDT

AdaptHealth Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	997.78M	580.47M	856.64M	805.86M	805.98M	792.5M	858.23M	804.03M	793.29M	744.63M	780.28M	557.65M	727.61M	706.2M	702.11M	653.29M	617.02M	482.12M
Cost of Revenue	920.81M	657.44M	543.35M	681.87M	690.37M	687.06M	709.82M	693.49M	673.4M	655.4M	699.32M	646.71M	610.01M	597.12M	591.62M	529.89M	490.72M	396.7M
Gross Profit	76.97M	-76.97M	313.3M	123.99M	115.61M	105.44M	148.41M	110.54M	119.89M	89.23M	80.96M	-89.06M	117.6M	109.08M	110.49M	123.41M	126.3M	85.42M
Operating Income	79.25M	23.17M	97.67M	63.49M	58.59M	57.06M	102.26M	-461.04M	54.26M	26.18M	26.73M	52.95M	59.18M	51.55M	69.08M	75.71M	65.41M	15.41M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	51.72M	-5.23M	70.71M	32.03M	27.78M	5.5M	-271.69M	-487.5M	20.44M	14.96M	3.16M	22.81M	24.1M	47.83M	33.49M	70.41M	92.39M	-5.34M
Net Income	14.67M	-7.21M	50.26M	22.86M	19.43M	-2.13M	-254.5M	-454.08M	13.98M	15.71M	-1.57M	13.4M	12.85M	38.21M	21.14M	48.09M	72.2M	-3.97M
Selling & General & Admin	97.44M	86.85M	225.61M	49.24M	57.01M	48.38M	46.16M	45.2M	50.08M	47.52M	37.45M	40.68M	42.55M	41.44M	34.92M	33.01M	42.95M	56.63M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	187M	-187M	607.67M	n/a	n/a	n/a	n/a	-3.32M	-2.08M	15.53M	16.78M	-182.69M	15.88M	16.09M	-1.13M	452K	-1.67M	519K
Operating Expenses	284.43M	-100.14M	204.61M	49.24M	57.01M	48.38M	46.16M	59.71M	65.63M	63.05M	54.23M	-142.01M	58.42M	57.53M	41.41M	47.7M	60.89M	70.01M
Interest Expense	27.53M	28.4M	29.73M	31.43M	33.04M	32.47M	33.49M	32.31M	32.55M	31.95M	30.51M	28.52M	25.61M	24.78M	25.61M	24.25M	23.15M	22.18M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-1.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.21B	557.3M	1.38B	742.37M	747.38M	735.44M	755.98M	753.2M	739.02M	718.45M	753.55M	504.7M	668.44M	654.65M	633.03M	577.58M	551.61M	466.71M
Income Tax Expense	35.89M	850K	19.31M	8.07M	7.25M	6.61M	-18.11M	-34.58M	5.4M	-1.71M	4.73M	5.58M	8.85M	5.6M	10.02M	12.15M	12.33M	-1.7M
Shares Outstanding (Basic)	134.9M	134.8M	134.57M	134.3M	133.22M	132.91M	132.99M	134.82M	134.29M	134.53M	133.42M	134.23M	134.33M	134.02M	132.47M	131.68M	129.66M	111.11M
Shares Outstanding (Diluted)	137.18M	134.8M	136.53M	136.53M	136.03M	132.91M	132.99M	134.98M	136.23M	135.98M	134.14M	137.58M	137.01M	138.48M	136.38M	140.32M	136.58M	116M
EPS (Basic)	0.10	-0.05	0.34	0.16	0.13	-0.02	-1.91	-3.37	0.10	0.11	-0.01	0.10	0.09	0.28	0.16	0.40	0.56	-0.04
EPS (Diluted)	0.10	-0.05	0.34	0.15	0.13	-0.02	-1.91	-3.36	0.09	-0.06	-0.01	0.10	0.09	0.28	0.15	0.20	0.12	-0.03
EBITDA	4.36M	117.52M	190.98M	154.22M	161.56M	144.23M	-137.75M	-347.15M	163.18M	149.64M	189.15M	154.98M	131.93M	157.82M	187.62M	150.04M	137.8M	94.52M
EBIT	n/a	23.17M	100.44M	63.46M	60.82M	38.37M	-237.8M	-454.79M	52.99M	46.92M	31.47M	51.33M	50.41M	73.31M	59.11M	94.67M	115.53M	16.85M
Depreciation & Amortization	-73.74M	94.34M	90.54M	90.76M	100.74M	105.86M	100.05M	107.64M	110.18M	102.73M	157.68M	99.72M	81.52M	84.51M	128.52M	69.83M	63.79M	47.21M